Previous Section | Index | Home Page |
Mr. Spring: To ask the Prime Minister how many people accompanied the Prime Minister to the G8 Summit; and how many officials represented the UK at the Summit. [132874]
The Prime Minister: I represented the United Kingdom at the Summit.
I was accompanied by five key No. 10 officials, five senior Foreign and Commonwealth Office officials, two senior officials from HM Treasury and an interpreter. In addition, 18 journalists accompanied me at their own expense.
28 Jul 2000 : Column: 976W
In line with the practice of previous Administrations, I was supported by the usual number of security and secure telecommunications staff that accompany a Prime Minister on an overseas visit.
Mr. Spring: To ask the Prime Minister if he will estimate the cost of (a) travel, (b) accommodation and (c) other expenses associated with United Kingdom attendance at the G8 Summit. [132876]
The Prime Minister: No. Details of costs are not yet available.
28 Jul 2000 : Column: 977W
Ms Shipley: To ask the Secretary of State for Health (1) during which month the Minister for Health will respond to the 1998 Review by Professor Sheila McLean of the Human Fertilisation and Embryology Act 1990; [126779]
(3) if he will make a statement on the issue of inheritance as raised in the review of the Human Fertilisation and Embryology Act 1990 by Professor Sheila McLean. [128774]
Yvette Cooper [holding answers 19 June and 23 June 2000]: Professor Sheila McLean made a number of recommendations about consent issues under the common law for the removal of human gametes (sperm and eggs) and the consent provisions in the Human Fertilisation and Embryology Act 1990 for their storage and use. The McLean report did not recommend making child birth registering retrospective. The report recommended that the law of succession should not be amended to secure succession rights for children born
28 Jul 2000 : Column: 978W
after the death of the sperm provider. We will make an announcement on the Government's response to the McLean report in August.
Mr. Edwards: To ask the Secretary of State for Health what plans he has to change hospital consultants' contracts to increase the proportion of them who work exclusively for the NHS. [128700]
Mr. Denham: Our proposals on the reform of hospital consultants' contracts are set out in "The NHS Plan: A Plan for Investment, A Plan for Reform", copies of which are available in the Library.
Mr. Jim Marshall: To ask the Secretary of State for Health what the outcome was of the Health Council held in Brussels on 29 June; and if he will make a statement. [129300]
Ms Stuart: I attended the Health Council on 29 June in Luxembourg on behalf of the United Kingdom.
The items in the table were discussed.
28 Jul 2000 : Column: 977W
28 Jul 2000 : Column: 979W
28 Jul 2000 : Column: 979W
Mr. Blizzard: To ask the Secretary of State for Health if he will make a statement on the incidence of tuberculosis among homeless and poorly housed people. [130728]
Yvette Cooper: Certain parts of the community--certain ethnic minority populations including immigrants from areas with a high prevalence for tuberculosis, older white people who were exposed to TB when they were younger, homeless people and HIV infected individuals--are at an increased risk from TB.
Information on tuberculosis rates in homeless people, along with recommendations for prevention and control, is contained in the June 1996 report of the Interdepartmental Working Group on Tuberculosis entitled "Tuberculosis and Homeless People, A review and recommendations for health professionals, local authorities and voluntary and support groups". Copies are available in the Library.
The Department has also funded The Passage Day and Nightshelter for the homeless to write a project on TB control and prevention, which we hope will be available soon. The aims of the report are to improve identification and cure rates for TB in homeless people and to develop
28 Jul 2000 : Column: 980W
a proactive education and awareness programme of TB aimed at homeless individuals and voluntary sector workers and volunteers.
Information on the incidence of tuberculosis among poorly housed people is not collected.
Dr. Gibson: To ask the Secretary of State for Health if he has plans to restore TB vaccination. [132428]
Yvette Cooper: Bacillus Calmette-Guerin (BCG) the vaccine used to protect against tuberculosis has been and is still used to protect those most at risk from TB such as health service and veterinary staff, contacts of people known to be suffering from active pulmonary TB, immigrants from countries with a high prevalence of TB and their children and infants wherever born, including this country. However, due to severe manufacturing problems encountered by the sole United Kingdom licensed source, Celltech Medeva, routine immunisation of 10 to 14-year-olds was suspended nationally in September 1999.
The Department did try to obtain UK licensed and batch released BCG vaccine from elsewhere before suspending the schools BCG immunisation programme. However, only Celltech Medeva vaccine meets these requirements at present. The Department has identified
28 Jul 2000 : Column: 981W
other manufacturers of BCG vaccine worldwide and is investigating these possible sources together with experts from the National Institutes for Biological Standards and Control, the Medicines Control Agency and NHS Purchasing Supply Agency. Products from different manufacturers vary in their composition and side effect profile, and we will need to be assured of the safety and efficacy of these products and that they satisfy current UK requirements.
Suspending the schools programme has allowed us to maintain supplies of the vaccine for all those at a higher risk of TB mentioned above. However we have remained committed to restarting the schools programme as soon as sufficient supplies of the vaccine were available. On 19 July 2000, the Department announced that there is now sufficient supply of vaccine to restart the routine schools programme initially in the London area, where the highest rate of TB in the country currently occurs. We hope to announce, by the end of the summer, when we will have enough vaccine to start the schools programme again in the rest of the country. Copies of the Department's press release of 19 July are available in the Library.
Next Section | Index | Home Page |